TrialArthritis research & therapy2013

Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.

Herbert S B Baraf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.